Clinical Trials

Lung Neoplasms, Motor Activity

NCT07627321 2026-06-04

PRAD2

39 enrolled

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07619599 2026-06-02

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

6 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07619911 2026-06-02

SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell Lung Cancer

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03228537 2026-05-29

Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

Other solid neoplasmThoracic

28 enrolled 17 charts

Mesothelioma, Malignant

NCT02959463 2026-05-27

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

Phase 1 Completed

25 enrolled 11 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05198830 2026-05-27

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

42 enrolled

Adenocarcinoma of Lung, Lung Neoplasms

NCT07609121 2026-05-27

Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC

160 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00334815 2026-05-26

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

29 enrolled 10 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

NCT02186847 2026-05-22

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

Phase 2 Completed

170 enrolled 19 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT06813664 2026-05-22

CURB-TKI

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02444741 2026-05-15

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Phase 1/2 Completed

124 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT04789486 2026-05-14

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Phase 1/2 Recruiting

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04929041 2026-05-13

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

Phase 2/3 Suspended

427 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05615142 2026-05-11

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

9 enrolled

NSCLC

NCT05092412 2026-05-08

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

30 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT06019468 2026-05-08

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

25 enrolled

Thymoma

NCT06116786 2026-05-08

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

Phase 1 Recruiting

126 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07146230 2026-05-06

SPRINT 2

52 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06217757 2026-05-05

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

Phase 1/2 Recruiting

45 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04902040 2026-04-30

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Phase 1/2 Terminated

19 enrolled 11 charts

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Lung Neoplasms

NCT05765825 2026-04-29

Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC

61 enrolled

Phase 1/2 Active not recruiting

Small Cell Lung Carcinoma

NCT06477523 2026-04-29

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

57 enrolled

SCLC, Extensive Stage

NCT06732258 2026-04-29

Low-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC

Phase 1 Withdrawn

Small Cell Lung Carcinoma

NCT02633514 2026-04-27

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Phase 3 Withdrawn

Thymoma

NCT06402708 2026-04-27

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Phase 3 Recruiting

172 enrolled

Thymoma

NCT02468024 2026-04-16

STABLE-MATES

Phase 3 Recruiting

272 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06141070 2026-04-14

ANDROMEDA

Phase 3 Recruiting

240 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02888743 2026-04-13

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

Phase NA Active not recruiting

110 enrolled 21 charts

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT06483308 2026-04-13

SHiP-Rt

37 enrolled

Lung Neoplasms

NCT06865339 2026-04-13

TRIPL

76 enrolled

NSCLC

NCT03410043 2026-04-06

Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study

173 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04245514 2026-04-02

Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06114108 2026-04-02

salVage

Phase NA Recruiting

128 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02905591 2026-03-25

XACT-LUNG

43 enrolled

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03391869 2026-03-23

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

339 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03313804 2026-03-11

Priming Immunotherapy in Advanced Disease With Radiation

Phase 2 Completed

76 enrolled 9 charts

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung

NCT04505267 2026-03-11

NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer

34 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05986318 2026-03-09

RESPIRE-ILD

98 enrolled

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

NCT04013542 2026-03-05

Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer

21 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04170946 2026-03-05

Talazoparib

Phase 1 Recruiting

24 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT06719700 2026-03-03

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

47 enrolled

Phase 3 Active not recruiting

Small Cell Lung Carcinoma

NCT03774732 2026-02-25

NIRVANA-LUNG

327 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07413952 2026-02-17

Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases

45 enrolled

NSCLC

NCT06610734 2026-02-09

SKY

202 enrolled

Small Cell Lung Cancer Extensive Stage

NCT05443971 2026-02-06

Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen

Phase 1 Terminated

4 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02525757 2026-02-04

MPDL3280A With Chemoradiation for Lung Cancer

52 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06794125 2026-02-04

PREVENT-LUNG

Phase NA Recruiting

141 enrolled